Anesthesia safety check for obesity surgery patients
NCT ID NCT02525016
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at the safety of giving lidocaine through a vein during weight-loss surgery. Fifty adults having laparoscopic bariatric surgery received lidocaine, and their blood levels were measured at several points. The goal was to confirm that using a dose based on adjusted body weight does not cause dangerous side effects like seizures or heart problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Edouard Herriot - Département d'anesthésie réanimation
Lyon, 69437, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?